Background To evaluate the effectiveness of Cardiac Magnetic Resonance Imaging (CMR) in evaluation of cardiac masses. Cardiac masses are a rare but important finding on cardiac imaging. Differentiating benign from malignant masses is crucial as an accurate diagnosis can affect the work up and management of the patient. To date very few studies have evaluated the effectiveness of CMR in aiding t...

abstract primary cardiac tumors are rare in all ages. their reported prevalence ranges from 0.001 to 0.03 percent in autopsy series. 25 percent of primary cardiac tumors are considered to be malignant, the majority of which are sarcomas. on account of the late presentation of symptoms in malignant heart masses, finding locally infiltrative tumors or systemically widespread cases at initial pres...

Cardiac masses represent a diagnostic challenge because decisions about treatment are based on imaging techniques. Echocardiography, magnetic resonance (MR) and computed tomography (CT) are fundamental for the detection, characterization, and staging of cardiac masses as well as for planning their treatment. Most primary cardiac tumors are benign; myxomas, papillary fibroelastomas, and lipomas ...

Abstract Background Cardiac masses (CM) are an extremely heterogeneous clinical scenario, including benign and malignant neoformations. After a first echocardiographic assessment, Computed Tomography (CCT) together with Magnetic Resonance (CMR) 18-Fluorodeoxyglucose Positron Emission (18-FDG-PET) represent second-line third-line imaging techniques to determine the nature of mass. However, data ...